These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 10896241

  • 21. A common neoepitope is created when the reactive center of C1-inhibitor is cleaved by plasma kallikrein, activated factor XII fragment, C1 esterase, or neutrophil elastase.
    de Agostini A, Patston PA, Marottoli V, Carrel S, Harpel PC, Schapira M.
    J Clin Invest; 1988 Aug; 82(2):700-5. PubMed ID: 2457036
    [Abstract] [Full Text] [Related]

  • 22. Activated factor XII levels are dependent on factor XII 46C/T genotypes and factor XII zymogen levels, and are associated with vascular risk factors in patients and healthy subjects.
    Ishii K, Oguchi S, Murata M, Mitsuyoshi Y, Takeshita E, Ito D, Tanahashi N, Fukuuchi Y, Oosumi K, Matsumoto K, Kitajima M, Yamamoto M, Watanabe G, Ikeda Y, Watanabe K.
    Blood Coagul Fibrinolysis; 2000 Apr; 11(3):277-84. PubMed ID: 10870808
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The regulation of human factor XIIa by plasma proteinase inhibitors.
    Pixley RA, Schapira M, Colman RW.
    J Biol Chem; 1985 Feb 10; 260(3):1723-9. PubMed ID: 2578463
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Fibrinolytic properties of activated FXII.
    Braat EA, Dooijewaard G, Rijken DC.
    Eur J Biochem; 1999 Aug 10; 263(3):904-11. PubMed ID: 10469157
    [Abstract] [Full Text] [Related]

  • 29. Characterization of monoclonal immunoglobulin a and g against shiga toxin binding subunits produced by intranasal immunization.
    Tanikawa T, Ishikawa T, Maekawa T, Kuronane K, Imai Y.
    Scand J Immunol; 2008 Oct 10; 68(4):414-22. PubMed ID: 18782271
    [Abstract] [Full Text] [Related]

  • 30. Conformational and sequential epitopes on the human granulocyte-colony stimulating factor molecule (hG-CSF) and their role in binding to human placenta receptors.
    Marino VJ, Sterin-Prync AE, Carbonetto CH, Roguin LP.
    Cytokine; 2001 Oct 21; 16(2):41-50. PubMed ID: 11683584
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. High affinity binding of factor XIIa to an electronegative surface controls the rates of factor XII and prekallikrein activation in vitro.
    Mitropoulos KA.
    Thromb Res; 1999 Apr 15; 94(2):117-29. PubMed ID: 10230897
    [Abstract] [Full Text] [Related]

  • 33. Rapid and cooperative binding of factor XII to human umbilical vein endothelial cells.
    Schousboe I.
    Eur J Biochem; 2001 Jul 15; 268(14):3958-63. PubMed ID: 11453989
    [Abstract] [Full Text] [Related]

  • 34. [Prothrombin--substrate for blood plasma kallikrein and factor XIIa].
    Baskova IP, Tiero A, Krizhevskaia IuV, Iarovaia GA, Mirkamalova EG.
    Biull Eksp Biol Med; 1983 Aug 15; 96(8):13-6. PubMed ID: 6603874
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Activation of the contact system of coagulation by a monoclonal antibody directed against a neodeterminant in the heavy chain region of human coagulation factor XII (Hageman factor).
    Nuijens JH, Huijbregts CC, Eerenberg-Belmer AJ, Meijers JC, Bouma BN, Hack CE.
    J Biol Chem; 1989 Aug 05; 264(22):12941-9. PubMed ID: 2473984
    [Abstract] [Full Text] [Related]

  • 37. [Evaluation of the factor XIIa assay kit].
    Munakata M, Komiyama Y, Mori T, Okuda K, Murakami T, Masuda M, Egawa H, Takahashi H.
    Rinsho Byori; 1996 Sep 05; 44(9):883-8. PubMed ID: 8911075
    [Abstract] [Full Text] [Related]

  • 38. Kallikrein-kinin system and fibrinolysis in hereditary angioedema due to factor XII gene mutation Thr309Lys.
    Bork K, Kleist R, Hardt J, Witzke G.
    Blood Coagul Fibrinolysis; 2009 Jul 05; 20(5):325-32. PubMed ID: 19474702
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Recombinant C1 inhibitor P5/P3 variants display resistance to catalytic inactivation by stimulated neutrophils.
    Eldering E, Huijbregts CC, Nuijens JH, Verhoeven AJ, Hack CE.
    J Clin Invest; 1993 Mar 05; 91(3):1035-43. PubMed ID: 8450033
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.